These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 30246507)
21. The Association Between Helicobacter pylori Infection and Nonalcoholic Fatty Liver Disease. Tang DM; Kumar S Curr Gastroenterol Rep; 2017 Feb; 19(2):5. PubMed ID: 28155087 [TBL] [Abstract][Full Text] [Related]
22. The effect of a low fructose and low glycemic index/load (FRAGILE) dietary intervention on indices of liver function, cardiometabolic risk factors, and body composition in children and adolescents with nonalcoholic fatty liver disease (NAFLD). Mager DR; Iñiguez IR; Gilmour S; Yap J JPEN J Parenter Enteral Nutr; 2015 Jan; 39(1):73-84. PubMed ID: 23976771 [TBL] [Abstract][Full Text] [Related]
23. Gamma glutamyl transferase is an independent determinant for the association of insulin resistance with nonalcoholic fatty liver disease in Bangladeshi adults: Association of GGT and HOMA-IR with NAFLD. Hossain IA; Rahman Shah MM; Rahman MK; Ali L Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S25-9. PubMed ID: 26482965 [TBL] [Abstract][Full Text] [Related]
24. Helicobacter pylori infection might have a potential role in hepatocyte ballooning in nonalcoholic fatty liver disease. Sumida Y; Kanemasa K; Imai S; Mori K; Tanaka S; Shimokobe H; Kitamura Y; Fukumoto K; Kakutani A; Ohno T; Taketani H; Seko Y; Ishiba H; Hara T; Okajima A; Yamaguchi K; Moriguchi M; Mitsuyoshi H; Yasui K; Minami M; Itoh Y J Gastroenterol; 2015 Sep; 50(9):996-1004. PubMed ID: 25622927 [TBL] [Abstract][Full Text] [Related]
25. Serum concentration of adiponectin, leptin and resistin in obese children with non-alcoholic fatty liver disease. Lebensztejn DM; Wojtkowska M; Skiba E; Werpachowska I; Tobolczyk J; Kaczmarski M Adv Med Sci; 2009; 54(2):177-82. PubMed ID: 20022856 [TBL] [Abstract][Full Text] [Related]
26. Helicobacter pylori infection is not associated with fatty liver disease including non-alcoholic fatty liver disease: a large-scale cross-sectional study in Japan. Okushin K; Takahashi Y; Yamamichi N; Shimamoto T; Enooku K; Fujinaga H; Tsutsumi T; Shintani Y; Sakaguchi Y; Ono S; Kodashima S; Fujishiro M; Moriya K; Yotsuyanagi H; Mitsushima T; Koike K BMC Gastroenterol; 2015 Feb; 15():25. PubMed ID: 25880912 [TBL] [Abstract][Full Text] [Related]
27. Central obesity and altered peripheral adipose tissue gene expression characterize the NAFLD patient with insulin resistance: Role of nutrition and insulin challenge. Paniagua JA; Escandell-Morales JM; Gil-Contreras D; Berral de la Rosa FJ; Romero-Jimenez M; Gómez-Urbano A; Sanchez-Lopez A; Bellido E; Poyato A; Calatayud B; Vidal-Puig AJ Nutrition; 2014 Feb; 30(2):177-85. PubMed ID: 24377452 [TBL] [Abstract][Full Text] [Related]
28. Potential role of Helicobacter pylori infection in nonalcoholic fatty liver disease. Li M; Shen Z; Li YM World J Gastroenterol; 2013 Nov; 19(41):7024-31. PubMed ID: 24222944 [TBL] [Abstract][Full Text] [Related]
29. A pilot study of the effects of chromium picolinate supplementation on serum fetuin-A, metabolic and inflammatory factors in patients with nonalcoholic fatty liver disease: A double-blind, placebo-controlled trial. Moradi F; Kooshki F; Nokhostin F; Khoshbaten M; Bazyar H; Pourghassem Gargari B J Trace Elem Med Biol; 2021 Jan; 63():126659. PubMed ID: 33045675 [TBL] [Abstract][Full Text] [Related]
30. Investigation of adropin and leptin levels in pediatric obesity-related nonalcoholic fatty liver disease. Sayın O; Tokgöz Y; Arslan N J Pediatr Endocrinol Metab; 2014 May; 27(5-6):479-84. PubMed ID: 24468600 [TBL] [Abstract][Full Text] [Related]
31. [Correlation between the inflammatory factors and adipocytokines with gestational diabetes mellitus and their change in puerperium]. Liu T; Fang Z; Yang D; Liu Q Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):436-9. PubMed ID: 22932110 [TBL] [Abstract][Full Text] [Related]
32. The relationship of circulating fetuin-a with liver histology and biomarkers of systemic inflammation in nondiabetic subjects with nonalcoholic fatty liver disease. Celebi G; Genc H; Gurel H; Sertoglu E; Kara M; Tapan S; Acikel C; Karslioglu Y; Ercin CN; Dogru T Saudi J Gastroenterol; 2015; 21(3):139-45. PubMed ID: 26021772 [TBL] [Abstract][Full Text] [Related]
33. Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease. Lemoine M; Ratziu V; Kim M; Maachi M; Wendum D; Paye F; Bastard JP; Poupon R; Housset C; Capeau J; Serfaty L Liver Int; 2009 Oct; 29(9):1431-8. PubMed ID: 19422483 [TBL] [Abstract][Full Text] [Related]
34. Adiponectin-leptin ratio for the early detection of lean non-alcoholic fatty liver disease independent of insulin resistance. Lu CW; Yang KC; Chi YC; Wu TY; Chiang CH; Chang HH; Huang KC; Yang WS Ann Med; 2023 Dec; 55(1):634-642. PubMed ID: 36790383 [TBL] [Abstract][Full Text] [Related]
35. NAFLD, Helicobacter species and the intestinal microbiome. Castaño-Rodríguez N; Mitchell HM; Kaakoush NO Best Pract Res Clin Gastroenterol; 2017 Dec; 31(6):657-668. PubMed ID: 29566909 [TBL] [Abstract][Full Text] [Related]
36. Long-term effects of aerobic plus resistance training on the adipokines and neuropeptides in nonalcoholic fatty liver disease obese adolescents. de Piano A; de Mello MT; Sanches Pde L; da Silva PL; Campos RM; Carnier J; Corgosinho F; Foschini D; Masquio DL; Tock L; Oyama LM; do Nascimento CM; Tufik S; Dâmaso AR Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1313-24. PubMed ID: 22932160 [TBL] [Abstract][Full Text] [Related]
37. Hepatic insulin resistance in NAFLD: relationship with markers of atherosclerosis and metabolic syndrome components. Privitera G; Spadaro L; Alagona C; Calanna S; Piro S; Rabuazzo AM; Purrello F Acta Diabetol; 2016 Jun; 53(3):449-59. PubMed ID: 26496770 [TBL] [Abstract][Full Text] [Related]
38. Severity of non-alcoholic fatty liver disease is associated with high systemic levels of tumor necrosis factor alpha and low serum interleukin 10 in morbidly obese patients. Paredes-Turrubiarte G; González-Chávez A; Pérez-Tamayo R; Salazar-Vázquez BY; Hernández VS; Garibay-Nieto N; Fragoso JM; Escobedo G Clin Exp Med; 2016 May; 16(2):193-202. PubMed ID: 25894568 [TBL] [Abstract][Full Text] [Related]
39. Serum C1q/TNF-related protein 9 is not related to nonalcoholic fatty liver disease. Zhang C; Zhou N; Qiu P; Fu Y; Liu Z; Li H; Yang X; Zhang L Cytokine; 2018 Oct; 110():52-57. PubMed ID: 29704818 [TBL] [Abstract][Full Text] [Related]
40. Increased Plasma Levels of Asymmetric Dimethylarginine in Nonalcoholic Fatty Liver Disease: Relation With Insulin Resistance, Inflammation, and Liver Histology. Boga S; Alkim H; Koksal AR; Bayram M; Ozguven MB; Ergun M; Neijmann ST; Ozgon G; Alkim C J Investig Med; 2015 Oct; 63(7):871-7. PubMed ID: 26244718 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]